Keyphrases
Atherosclerotic Cardiovascular Disease (ASCVD)
28%
Cardiovascular Outcomes
100%
Cardiovascular Risk
14%
Cardiovascular Survival
100%
Cerebrovascular Disease
28%
Composite Endpoint
28%
Confidence Interval
42%
Congestive Heart Failure
28%
Cox Survival Model
14%
Decreased Risk
14%
Disease-modifying Antirheumatic Drugs (DMARDs)
28%
Hazard Ratio
42%
Long-term Survival
14%
Mortality Hazard
14%
Non-associated
42%
Peripheral Arterial Disease
28%
Rheumatoid Arthritis
100%
Risk of Death
42%
Risk Reduction
14%
Subgroup Analysis
14%
TNF Blockade
14%
TNF-α Antagonists
100%
Tumor Necrosis Factor-α
100%
US Veterans
14%
Medicine and Dentistry
Arteriosclerosis Obliterans
22%
Cardiovascular System
100%
Cerebrovascular Disease
22%
Congestive Heart Failure
22%
Disease Modifying Antirheumatic Drug
11%
Disease-Modifying Antirheumatic Drug
11%
Hazard Ratio
33%
Inflammatory Arthritis
100%
Long Term Survival
11%
Proportional Hazards Model
11%
Rheumatoid Arthritis
100%
Subgroup Analysis
11%
Tumor Necrosis Factor
100%
Pharmacology, Toxicology and Pharmaceutical Science
Cerebrovascular Disease
22%
Congestive Heart Failure
22%
Coronary Artery Atherosclerosis
22%
Disease Modifying Antirheumatic Drug
11%
Inflammatory Arthritis
100%
Long Term Survival
11%
Peripheral Occlusive Artery Disease
22%
Rheumatoid Arthritis
100%
Tumor Necrosis Factor
100%
Immunology and Microbiology
Artery
22%
Disease-Modifying Antirheumatic Drug
11%
Inflammatory Arthritis
100%
Long Term Survival
11%
Tumor Necrosis Factor
100%